FDA Inspection
Amneal Pharmaceuticals Inc.Amneal Pharmaceuticals Inc. – FDA Inspection, Jul 10, 2018
Record Details
This FDA Inspection record concerns Amneal Pharmaceuticals Inc., with an inspection on July 10, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Karen L. Kosar (FDA Associated Person)
- Peter S. Diak (Issuing Officer)
- Tara K. Carmody (FDA Associated Person)
View Company Profile
ID · 2704b680-9f95-4854-8ed5-328212f590ab
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1065634
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Amneal Pharmaceuticals Inc.
15| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2026 | Not classified | New York District Office | |
| August 28, 2026 | Not classified | New York District Office | |
| June 7, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 20, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 18, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Amneal Pharmaceuticals Inc.
- FDA Inspection 1305048 - 2026-09-25
- FDA Inspection 1286562 - 2026-08-28
- FDA Inspection 1207398 - 2023-06-07
- FDA Inspection 1116040 - 2019-12-20
- FDA Inspection 1089916 - 2019-04-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.